Published in J Immunol on July 01, 1979
Viral myocarditis. A review. Am J Pathol (1980) 3.33
Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis. J Exp Med (1985) 1.55
Clinical and experimental aspects of viral myocarditis. Clin Microbiol Rev (1989) 1.41
In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis. Am J Pathol (1987) 1.08
Assessment of cell-mediated immunity against coxsackievirus B3-induced myocarditis in a primate model (Papio papio). Infect Immun (1981) 1.04
Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis. Infect Immun (1983) 0.94
Levamisole exacerbates coxsackievirus B3-induced murine myocarditis. Infect Immun (1983) 0.93
Monoclonal anti-idiotypic antibodies regulate the expression of virus-induced murine myocarditis. Infect Immun (1989) 0.87
Autoanti-idiotypes exhibit mimicry of myocyte antigens in virus-induced myocarditis. J Virol (1991) 0.79
Coxsackievirus B3 infection alters plasma membrane of neonatal skin fibroblasts. J Virol (1986) 0.78
Antimyocarditic activity of the guanine derivative BIOLF-70 in a coxsackievirus B3 murine model. Antimicrob Agents Chemother (1985) 0.77
Adoptively transferred anti-idiotype pulsed B cells mediate autoimmune myocarditis. Infect Immun (1992) 0.75
Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect Immun (1980) 6.19
Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization. J Clin Microbiol (1990) 3.75
Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to buccal cells. J Infect Dis (1981) 3.51
Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients. Infect Immun (1980) 3.23
Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay. J Infect Dis (1978) 2.60
Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun (1978) 2.15
Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J Med Virol (1979) 1.94
Correlation between the prevalence of certain fungi and sick building syndrome. Occup Environ Med (1998) 1.68
Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease. Infect Immun (1983) 1.60
Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae. Infect Immun (1982) 1.59
Transcription of the genomes of type 1 and type 3 reoviruses. J Virol (1968) 1.56
Echovirus 22 is an atypical enterovirus. J Virol (1990) 1.55
Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells. Infect Immun (1984) 1.54
Extracellular neuraminidase production by group B streptococci. Infect Immun (1977) 1.53
Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci U S A (1992) 1.49
Growth and amino acid requirements of various strains of group B streptococci. J Clin Microbiol (1978) 1.47
Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes (2000) 1.46
The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology (2000) 1.46
Extracellular polysaccharide production by Klebsiella pneumoniae and its relationship to virulence. Can J Microbiol (1985) 1.44
Factors influencing release of type III antigens by group B streptococci. Infect Immun (1981) 1.41
An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch Virol (1994) 1.40
Role of salivary protease activity in adherence of gram-negative bacilli to mammalian buccal epithelial cells in vivo. J Clin Invest (1981) 1.40
Kinetic and chemical analyses of the biologic significance of lipoteichoic acids in mediating adherence of serotype III group B streptococci. Infect Immun (1985) 1.33
Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol (1993) 1.32
Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue. J Immunol (1978) 1.27
Production of an extracellular toxic complex by various strains of Klebsiella pneumoniae. Infect Immun (1987) 1.26
Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains. J Virol (1984) 1.26
Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol (1988) 1.25
Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model. Infect Immun (1981) 1.24
Pseudomonas aeruginosa exoproducts as pulmonary virulence factors. Can J Microbiol (1983) 1.23
Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins on particulates smaller than conidia. Appl Environ Microbiol (2005) 1.22
Importance of a lipopolysaccharide-containing extracellular toxic complex in infections produced by Klebsiella pneumoniae. Infect Immun (1985) 1.19
Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J Med Virol (2000) 1.19
Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. J Immunol (1986) 1.18
Reovirus-induced ribonucleic acid polymerase. J Virol (1968) 1.17
Extracellular antigens of serotype III group B streptococci. Infect Immun (1980) 1.16
An encephalomyocarditis virus epizootic in a baboon colony. Lab Anim Sci (1992) 1.16
Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity. Adv Virus Res (1998) 1.15
Fragmentation of RNA in virus particles of rhinovirus type 14. J Virol (1974) 1.15
Protease production by clinical isolates of type III group B streptococci. J Clin Microbiol (1980) 1.12
Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins in the indoor environment. Appl Environ Microbiol (2005) 1.11
Isolation of Coxsackievirus B3 temperture-sensitive mutants and their assignment to complementation groups. Biochem Biophys Res Commun (1976) 1.11
Inhibition of Mengo virus by interferon. J Bacteriol (1966) 1.10
Murine natural killer cells limit coxsackievirus B3 replication. J Immunol (1987) 1.10
Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor. Virology (1998) 1.10
In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis. Am J Pathol (1987) 1.08
Differential effects of myocarditic variants of Coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage. Lab Invest (1991) 1.08
Characterization of neuraminidases produced by various serotypes of group B streptococci. Infect Immun (1987) 1.07
Effect of chlorine dioxide gas on fungi and mycotoxins associated with sick building syndrome. Appl Environ Microbiol (2005) 1.05
Synthesis of ribonucleic acids in KB cells infected with rhinovirus type 14. J Gen Virol (1973) 1.05
Release of fibronectin-lipoteichoic acid complexes from group A streptococci with penicillin. Infect Immun (1986) 1.05
Assessment of cell-mediated immunity against coxsackievirus B3-induced myocarditis in a primate model (Papio papio). Infect Immun (1981) 1.04
Properties and origins of infectious rhinovirus type 14 particles of different buoyant densities. J Virol (1975) 1.03
Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model. Infect Immun (1979) 1.02
Production of extracellular material by streptococci associated with subacute bacterial endocarditis. Infect Immun (1977) 1.02
Destruction of L cells by Mengo virus: use of interferon to study the mechanism. J Virol (1968) 0.99
Ameliorating effect of IFN-beta and anti-IFN-beta on coxsackievirus B3-induced myocarditis in mice. J Interferon Res (1985) 0.95
Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis. Infect Immun (1983) 0.94
Levamisole exacerbates coxsackievirus B3-induced murine myocarditis. Infect Immun (1983) 0.93
Autoimmune determinants of rheumatic carditis: localization of epitopes in human cardiac myosin. Eur Heart J (1991) 0.93
Antibody response to Pseudomonas aeruginosa exoproducts in cancer patients. J Clin Microbiol (1982) 0.92
Purification and partial characterization of neuraminidase from type III group B streptococci. J Bacteriol (1980) 0.92
Fragility of the rhinovirus type 14 genome to incubation at 60 degrees. Intervirology (1980) 0.92
Airborne microbial flora in a cattle feedlot. Appl Environ Microbiol (2002) 0.92
Immune response to pulmonary injection of Pasteurella haemolytica-impregnated agar beads followed by transthoracic challenge exposure in goats. Am J Vet Res (1990) 0.91
Complete and apparently specif local tumor regression using syngeneic or xenogeneic "tumor-immune" RNA extracts. Cancer Res (1975) 0.91
Salicylate or bismuth salts enhance opsonophagocytosis of Klebsiella pneumoniae. Infection (1992) 0.91
Immunochemistry and end-group analyses of group A streptococcal M proteins. Infect Immun (1972) 0.91
Immunopathologic basis of myocardial injury. Cardiovasc Clin (1988) 0.90
Monkey to human transfer of delayed hypersensitivity in vitro with RNA extracts. Cell Immunol (1972) 0.90
Extracellular neuraminidase production by clinical isolates of group B streptococci from infected neonates. J Clin Microbiol (1980) 0.90
Protease production by Streptococcus sanguis associated with subacute bacterial endocarditis. Infect Immun (1982) 0.88
Effect of interferon on synthesis of ssRNA in reovirus type 3-infected L cell cultures. Biochem Biophys Res Commun (1972) 0.88
Serotyping and enzyme characterization of Pasteurella haemolytica and Pasteurella multocida isolates recovered from pneumonic lungs of stressed feeder calves. Curr Microbiol (1997) 0.88
Salicylate potentiates amikacin therapy in rodent models of Klebsiella pneumoniae infection. J Infect Dis (1993) 0.87
Detection of enteroviruses in cell cultures by using in situ transcription. J Clin Microbiol (1992) 0.87
Neuraminidase production by a Streptococcus sanguis strain associated with subacute bacterial endocarditis. Infect Immun (1983) 0.84
Characterization of group A streptococcal M-proteins purified by two methods. Can J Microbiol (1976) 0.84
Factors influencing the adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Rev Infect Dis (1984) 0.84
Cellular immune responses in mice challenged with an amyocarditic variant of Coxsackievirus B3. J Med Virol (1985) 0.84
Coxsackievirus group B replication in cultured fetal baboon aortic smooth muscle cells. J Med Virol (1986) 0.84
Salicylate-enhanced exposure of Klebsiella pneumoniae subcapsular components. Infection (1996) 0.83
Interspecies "transfer" of delayed hypersensitivity in vitro with RNA extracts. J Immunol (1970) 0.83
Alpha-helical coiled-coil molecules: a role in autoimmunity against the heart. Clin Immunol Immunopathol (1993) 0.83